213 — New Haven, Connecticut

213 is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

213 has participated in 1 clinical trials.

Therapeutic areas: Parenchymous Tissue Surgical Bleeding.

Sponsors: Instituto Grifols, S.A..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 213?

213 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 213 conducted?

213 has 1 clinical trials on record. Their work covers Parenchymous Tissue Surgical Bleeding.

Is 213 accredited by Crixeo Health?

213 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 213?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.